Skip to content

Nature of the Link Between Executive Functions and Theory of Mind in Multiple Sclerosis

Nature of the Link Between Executive Functions and Theory of Mind in Multiple Sclerosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04806217
Acronym
TDE-SEP
Enrollment
40
Registered
2021-03-19
Start date
2022-07-01
Completion date
2024-01-01
Last updated
2022-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Multiple sclerosis, Theory of Mind, Nonverbal false belief task, Cognitive functions, Inhibition and inference abilities

Brief summary

The purpose of this study is to explore inhibition and inference abilities in The Theory of Mind skills in multiple sclerosis patients using the Theory of Mind task.

Detailed description

Multiple sclerosis is an autoimmune inflammatory disease of the central nervous system. It can cause lesions responsible for motor, ocular, sensory and cognitive symptoms. The Theory of Mind and the primary facial emotions recognition (anger, joy, fear, surprise, sadness, disgust) are two processes of social cognition that play a role in the social interactions and social reasoning. The Theory of Mind is defined by the ability to understand the other person including thoughts, beliefs and desires that are unique and that may be different from our own. In multiple sclerosis, difficulties in social cognition are associated with cognitive disorders, (even if the link with a deficit in executive functions remains debated). Indeed, when attributing a mental state to another person is needed,it is mandatory to put ourselves in the other person's place to adopt another perspective. Thus, several executive functions are required: working memory to maintain and manipulate several perspectives, flexibility to switch from one perspective to another one, and finally the inhibition of our own perspective to adopt the other's point of view. The Theory of Mind's assessment uses nonverbal false belief task which assesses the ability to inhibit its own perspective to infer the mental state of another and the ability to change its perspective to adopt another's. Thus, the purpose of this study is to explore inhibition and inference abilities in The Theory of Mind skills in multiple sclerosis patients using the Theory of Mind task.

Interventions

OTHERTheory of Mind

Patients will be submitted to different neuropsychological tests used in routine and the non-verbal false belief task through in the Theory of Mind

Sponsors

Lille Catholic University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

People : * With multiple sclerosis * Age ≥ 18 years old * Not objecting to the use of their data

Exclusion criteria

* Any associated neurological pathology or severe or chronic somatic disease (cancer) * Visual and/or auditory disorders that do not allow for test taking * Uncontrolled major psychiatric disorders * Recent treatment with corticosteroids (less than 4 weeks before the evaluation) * Patients under guardianship, curatorship or safeguard of justice * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Number of correct answers to the unknown reality false belief tasksDay 0The number of correct answers to the unknown reality false belief tasks out of 12 tests will allow to obtain a mental state inference score
Number of correct answers to the known reality false belief tasksDay 0The number of correct answers to the known reality false belief tasks out of 12 tests will allow to obtain a score for inhibition of its own perspective

Secondary

MeasureTime frameDescription
Symbol Digit Modalities Test (SDMT)Day 0Coding test in which the patient has 90 seconds to state orally the correspondence of numbers (from 1 to 9) to 9 different symbols (matched according to a matching standard). The correct answers number is measured.
Stroop testDay 0The Stroop test is used to evaluate executive functions, especially inhibition abilities and sensitivity to interference. This test offers 3 situations in which performance is measured by the time taken by the patient for each situation and the number of uncorrected errors.
California Verbal Learning Test (CVLT)Day 0Verbal episodic memory abilities will be measured through the Learning test of a 16 words list belonging to 4 distinct semantic categories (flowers, fish, clothes, fruit). The list is presented 5 times to the patient who must remember it immediately after each presentation, after the presentation of a second interfering list and after a 20-minute delay. A main score is extracted.
Verbal fluency testDay 0The verbal fluency test evaluates executive functions, and more specifically the spontaneous flexibility's abilities. The performance is evaluated by the number of different words cited.
Beck Depression Inventory (BDI)Day 0The Beck Depression Inventory is used to assess depressive disorders. It is a 13-items self-questionnaire rated from 0 (no problem) to 3 (maximum severity of this symptom). The depression's severity is assessed by classifying the total score into 3 levels of intensity: \<3: Normal; 3-8: Borderline; \>8: Depressed.
Trail Making testDay 0The Trail Making Test is used to evaluate executive functions especially the cognitive flexibility abilities. The subject's performance is evaluated by the time taken by the subject, the total number of errors and the number of perseveration errors.
Brief Visuo-spatial Memory Test (BVMT)Day 0Learning test in episodic visuo-spatial memory of 6 simple geometrical drawings. This test presents 3 phases during which the sheet containing the 6 drawings is presented to the participant for 10 seconds, followed by an immediate recall phase (free hand reproduction of the drawings). A delayed recall phase (at 7 minutes) and a delayed recognition phase (among 12 distractors) is also proposed. A main score is extracted.

Contacts

Primary ContactAmélie Lansiaux, MD, PhD
lansiaux.amelie@ghicl.net03.20.22.52.69
Backup ContactAmel Boulafa
boulafa.amel@ghicl.net03.20.22.52.69

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026